CTNM vs GWW · $429.6M cap vs P/E 27, rev $9.76B
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) versus WW Grainger Inc (GWW) — a side-by-side from cached financials, not a winner call.
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is a biotechnology company listed on US.
WW Grainger Inc (GWW) is a industrial distribution company listed on US.
Latest reported CTNM revenue for 2024-09-30 was $0. Net income was -$27.7M. CTNM currently screens at market cap $429.6M.
Latest reported GWW revenue for 2026-06-30 was $9.76B. Net income was $1.13B. GWW currently screens at market cap $50.34B and trailing P/E 26.9.
CTNM currently screens at market cap $429.6M. GWW currently screens at market cap $50.34B and trailing P/E 26.9.
Not investment advice. Open the CTNM and GWW stock pages for the full models.
Not investment advice.